Alexandria Co for Pharmaceuticals & Chemical Industries (AXPH.CA)

Also known as:  Alex Co. Pharma, Alexandria Pharmaceuticals
Data delayed by 15 minutes
126.59 EGP 0.000.00%
As of 30 JUN 2020 - GMT|Egypt SE

Alex Co. Pharma Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
7.963%
P/E (Last 12 Month)
5.525
Upside
-
Target Price (Mean)
-
52Wk
85.0 19 MAR
131.65 09 JUN

Open
Data not available
Previous Close
126.59 EGP
Turnover
Data not available
EPS
22.912 EGP
Volume
0
Transactions
0
Market Cap
632.95M EGP
IPO Date
27-Feb-1995
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About Alexandria Co for Pharmaceuticals & Chemical IndustriesLast updated on: 22 January 2018

Business Summary
Manufacture of generic drugs, dental cartridges, medicated adhesive tapes, plasters, surgical gloves and sterile gauze dressing,eye drops, vitamins and veterinary products.
Country of Incorporation
Ownership Type
Established In
1962
Primary Sector
Stock Listing
IDStock TypeCurrencyExchangeSymbol
AXPH.CASEOrdinaryEGPEgypt SEAXPH

Contact details

Primary address
Alexandria Co for Pharmaceuticals & Chemical Industries Building
Gamila Abou Herid Road
Al Awayed Area
21511
Egypt
Alexandria
CONTACT
Region
Alexandria
More

WHO halts malaria drug in COVID-19 trials

The World Health Organization said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalized patients with COVID-19 after they failed to reduce mortality. This report produced by Jillian Kitchener.

Reuters Videos - Saturday 4 July 2020
All Health Care News

GCC IPO market could recover in H2

Saudi Arabia and the UAE will lead the IPO activity as eight IPOs are expected to be launched in the second half or by early 2021

Khaleej Times - 1 day ago
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Dr Abla Youssef Abdullah
Managing Director
Mr Mohammed Khalifa
Information Technology Director
Dr Mohammed Ashraf
Head of Marketing

Board Members

Dr Abla Youssef Abdullah
Chairperson and director representing Drug Holding Company
Dr Mohammed Hasan Suleiman Rabih
Director
Mr Saifuddine Ahmad Abdulmoati
Director
More

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
CAIRO PHARMAC.36.010 EGP0.00
EGYPT INTL PHRM52.900 EGP0.00
MINAPHARM PHARMA81.700 EGP0.00
ARAB PHARM58.970 EGP0.00
GLAXO EGYPT14.600 EGP0.00
More

Sunday Outlook: Oil falls, dollar rises on virus fears

Sunday Outlook: Oil falls, dollar rises on virus fears

Oil falls below $43/bbl on virus fears

More

Most Viewed Stocks

Stock Screener

More